Phenylbutazone increases right atrial pressure and heart rate of running horses.
Abstract: The effect of inhibition of cyclooxygenase activity on the hemodynamic response to exertion was examined in 6 horses. Rates of O2 consumption and CO2 production and carotid, pulmonary arterial, and right atrial pressures were measured while the horses performed a standardized exercise test on a treadmill after treatment with phenylbutazone or a placebo. Phenylbutazone (8.8 mg/kg p.o. for 2 days and 4.4 mg/kg i.v. 60 min before exertion) abolished the exertion-induced increases in plasma 6-ketoprostaglandin F1 alpha and thromboxane B2 concentrations, confirming inhibition of cyclooxygenase activity. Phenylbutazone treatment resulted in significantly (P < 0.05) higher heart rates and right atrial pressures during exertion than did treatment with placebo, which may have been due to increased myocardial sensitivity to sympathetic stimulation and/or decreased venous compliance. There was not a detectable effect of phenylbutazone on carotid or pulmonary arterial pressures, O2 consumption, CO2 production, or blood lactate concentration. Changes in plasma volume during exertion were not influenced by phenylbutazone. These results demonstrate that cyclooxygenase products likely mediate or modulate some of the systemic hemodynamic responses to exertion in horses.
Publication Date: 1996-07-01 PubMed ID: 8828679DOI: 10.1152/jappl.1996.81.1.312Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigates the influence of phenylbutazone, a cyclooxygenase inhibitor, on the cardiovascular responses in exercising horses. The findings suggest that phenylbutazone elevates heart rate and right atrial pressure during physical exertion, without noticeably affecting other hemodynamic parameters.
Study Design and Methodology
- The research was conducted on six horses which were subjected to a systematic exercise test on a treadmill.
- During the experiment, measurements were taken for rates of O2 consumption and CO2 production, and pressures in the carotid, pulmonary arterial, and right atrial areas.
- Testing was done after the horses were treated with either phenylbutazone, a known cyclooxygenase inhibitor, or a placebo for comparison.
- The dosage of phenylbutazone given was 8.8 mg/kg orally for two days and 4.4 mg/kg intravenously 60 minutes prior to exertion.
Main Findings
- The use of phenylbutazone resulted in an elimination of the usually observed increase in plasma 6-ketoprostaglandin F1 alpha and thromboxane B2 concentrations during exertion. This confirmed the successful inhibition of the cyclooxygenase activity.
- Phenylbutazone treatment led to noticeably (P < 0.05) higher heart rates and right atrial pressures during exertion when compared to the placebo-treated horses.
- This increase in heart rate and right atrial pressure due to phenylbutazone may have been triggered by an enhanced myocardial sensitivity to sympathetic stimulation or a reduction in venous compliance.
- No discernable impact of phenylbutazone was found on carotid or pulmonary arterial pressures, O2 consumption, CO2 production, or blood lactate concentration.
- Phenylbutazone also did not affect changes in plasma volume during exertion.
Conclusion and Implications
- The results indicate that cyclooxygenase byproducts likely play a role in mediating or altering some systemic hemodynamic responses to exertion in horses.
- This study, therefore, highlights the influence of cyclooxygenase activity on certain cardiovascular responses during physical exertion. The specific role of such influence warrants further investigation.
- The knowledge gained from this study could be important for understanding the physiological responses of horses during physical exertion, which could potentially influence strategies for managing cardiovascular health in these animals.
Cite This Article
APA
Mitten LA, Hinchcliff KW, Pate JL.
(1996).
Phenylbutazone increases right atrial pressure and heart rate of running horses.
J Appl Physiol (1985), 81(1), 312-317.
https://doi.org/10.1152/jappl.1996.81.1.312 Publication
Researcher Affiliations
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Ohio State University, Columbus 43210-1089, USA.
MeSH Terms
- 6-Ketoprostaglandin F1 alpha / blood
- Animals
- Atrial Function
- Blood Pressure / drug effects
- Blood Proteins / metabolism
- Carbon Dioxide / blood
- Cardiac Catheterization
- Cardiac Output / drug effects
- Cardiac Output / physiology
- Cyclooxygenase Inhibitors / pharmacology
- Dinoprostone / blood
- Female
- Heart Atria / drug effects
- Heart Rate / drug effects
- Horses / physiology
- Lactic Acid / blood
- Oxygen Consumption / drug effects
- Oxygen Consumption / physiology
- Phenylbutazone / pharmacology
- Physical Exertion / physiology
- Thromboxane B2 / blood
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists